FDA Coronavirus (COVID-19) Update: October 25th, 2020
October 25, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
On Thursday, the FDA approved Veklury (remdesivir), the first drug approved to treat COVID-19 Coronavirus, for use in adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 Coronavirus requiring hospitalization.
Coronavirus
FDA Approves First Treatment for COVID-19 Coronavirus
October 24, 2020
Silver Spring, MD – The U.S. Food and Drug Administration has approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 Coronavirus requiring hospitalization.
Coronavirus
FDA Coronavirus (COVID-19) Update: September 26th, 2020
September 26, 2020
Silver Spring, MD – The U.S. Food and Drug Administration has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
Coronavirus
FDA Coronavirus (COVID-19) Update: August 28th, 2020
August 29, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) continues to take action in the ongoing response to the COVID-19 Coronavirus pandemic:
The FDA is warning consumers about alcohol-based hand sanitizers that are being packaged in containers that may appear as food or drinks and may put consumers at risk of serious injury or death if ingested.
Coronavirus
FDA Coronavirus (COVID-19) Update: August 22nd, 2020
August 22, 2020
Silver Spring, MD – The U.S. Food and Drug Administration has announced that it has taken the following actions in its ongoing response effort to the COVID-19 Coronavirus pandemic:
Coronavirus
FDA Coronavirus (COVID-19) Update: August 20th, 2020
August 20, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) today announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA issued the third Emergency Use Authorization (EUA) for a COVID-19 Coronavirus antigen test.
Coronavirus
FDA Coronavirus (COVID-19) Update: August 17th, 2020
August 18, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA issued Yale School of Public Health an emergency use authorization (EUA) for its SalivaDirect COVID-19 Coronavirus diagnostic test, which uses a new method of processing saliva samples when testing for COVID-19 Coronavirus.
Coronavirus
FDA Coronavirus (COVID-19) Update: August 16th, 2020
August 16, 2020
Washington, D.C. – The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) to Yale School of Public Health for its SalivaDirect COVID-19 Coronavirus diagnostic test, which uses a new method of processing saliva samples when testing for COVID-19 Coronavirus infection.
Coronavirus
FDA Coronavirus (COVID-19) Update: August 15th, 2020
August 15, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has taken the following actions in its ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA is providing a device shortage list as part of the implementation of section 506J of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Coronavirus
FDA Coronavirus (COVID-19) Update: August 13th, 2020
August 13, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
Today, the FDA published an online Consumer Update with tips on how we can each take some simple steps to help slow the spread of the coronavirus disease and protect ourselves, our families and our communities.
Coronavirus
